These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Treatment of mastocytosis: pharmacologic basis and current concepts. Marone G; Spadaro G; Granata F; Triggiani M Leuk Res; 2001 Jul; 25(7):583-94. PubMed ID: 11377684 [TBL] [Abstract][Full Text] [Related]
11. Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome. Asawa A; Simpson KH; Bonds RS Ann Allergy Asthma Immunol; 2015 Jun; 114(6):443-6. PubMed ID: 25868710 [No Abstract] [Full Text] [Related]
12. [Systemic infantile mastocytosis: about a case with respiratory and digestive involvement]. Chemli J; Krid S; Tfefha A; Abroug S; Harbi A Arch Pediatr; 2003 Oct; 10(10):898-902. PubMed ID: 14550980 [TBL] [Abstract][Full Text] [Related]
13. Mast cell activation syndromes. Lee MJ; Akin C Ann Allergy Asthma Immunol; 2013 Jul; 111(1):5-8. PubMed ID: 23806452 [No Abstract] [Full Text] [Related]
15. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches]. Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358 [TBL] [Abstract][Full Text] [Related]
16. Systemic mast cell disease: a review of the literature with special focus on the gastrointestinal manifestations. Debeuckelaere S; Schoors DF; Devis G Acta Clin Belg; 1991; 46(4):226-32. PubMed ID: 1683083 [TBL] [Abstract][Full Text] [Related]
17. The treatment of mastocytosis: an overview. Metcalfe DD J Invest Dermatol; 1991 Mar; 96(3 Suppl):55S-56S; discussion 56S-59S, 60S-65S. PubMed ID: 16799611 [TBL] [Abstract][Full Text] [Related]